Craven P A, Saito R, DeRubertis F R
J Clin Invest. 1983 Oct;72(4):1365-75. doi: 10.1172/JCI111093.
The role of local prostaglandin (PG) synthesis in the modulation of the proliferative activity of colonic epithelium was examined in rat colon. Experimental rats were given either indomethacin (5 mg/kg s.c. every 8 h for three doses) or aspirin (0.5 g/100 g diet for 3 d). In rats treated with indomethacin or aspirin, the incorporation of [3H]thymidine (dThd) into DNA in vivo was increased approximately twofold over control in mucosal scrapings from distal colon, and approximately threefold over control in the proliferating pool of epithelial cells isolated from distal colon. [3H]dThd incorporation into DNA was also examined ex vivo immediately after distal colonic resection. It was approximately twofold higher in mucosa of colonic segments (1-h incubation) from rats treated with indomethacin or aspirin in vivo, compared with corresponding values of segments from control rats. Immunoreactive (i) prostaglandin E (PGE), the dominant PG product of colon segment incubates by high-performance liquid chromatography analysis of [14C]arachidonate metabolites, was markedly (95%) reduced in the media of 1-h colon incubates from indomethacin- or aspirin-treated rats, compared with control rats. Moreover, the cyclic (c)AMP content of mucosa of segments from indomethacin- or aspirin-treated rats was significantly lower than that of control rats. Prolonged incubation (4-24 h) of colonic segments from indomethacin-treated rats, in the absence of indomethacin in vitro, led to an eventual return of [3H]dThd incorporation into DNA, iPGE, and mucosal cAMP to control values. Conversely, inclusion of indomethacin (0.25 mM) in the incubations (6 h) of colonic segments from indomethacin-treated rats resulted in persistent suppression of iPGE and mucosal cAMP, as well as persistent enhancement of [3H]dThd incorporation into mucosal DNA. However, incubation of colonic segments from control rats (no in vivo drug exposure) with indomethacin or aspirin in vitro for periods up to 24 h failed to alter DNA synthesis, despite marked reduction in media iPGE and lower mucosal cAMP. The latter observations suggested that additional in vivo factors initiated the enhancement of DNA synthesis in indomethacin- or aspirin-treated rats. Exogenous PGE2, D2, I2, or F2 alpha, each of which increased the endogenous mucosal cAMP content of incubated colonic segments from control, indomethacin- or aspirin-treated rats, all suppressed [3H]dThd incorporation into mucosal DNA in vitro. Dibutyryl cAMP, but not dibutyryl cGMP, had an analogous suppressive effect on in vitro [3H]dThd incorporation into DNA. Thus, the present observations are consistent with an inhibitory action of endogenous colonic PG synthesis on the proliferative activity of colonic epithelium. This action may be mediated through cAMP.
在大鼠结肠中研究了局部前列腺素(PG)合成在调节结肠上皮细胞增殖活性中的作用。给实验大鼠注射吲哚美辛(每8小时皮下注射5mg/kg,共三剂)或阿司匹林(0.5g/100g饮食,持续3天)。在接受吲哚美辛或阿司匹林治疗的大鼠中,远端结肠黏膜刮片中[3H]胸苷(dThd)掺入DNA的量比对照组增加了约两倍,从远端结肠分离的上皮细胞增殖池中增加了约三倍。在远端结肠切除术后立即进行体外[3H]dThd掺入DNA的检测。与对照组大鼠相应节段的值相比,体内接受吲哚美辛或阿司匹林治疗的大鼠结肠节段(孵育1小时)黏膜中该值约高两倍。通过高效液相色谱分析[14C]花生四烯酸代谢产物,结肠节段孵育物中主要的PG产物免疫反应性(i)前列腺素E(PGE),在吲哚美辛或阿司匹林治疗的大鼠孵育1小时的结肠培养液中比对照组大鼠显著降低(95%)。此外,吲哚美辛或阿司匹林治疗的大鼠节段黏膜中的环(c)AMP含量明显低于对照组大鼠。在体外无吲哚美辛的情况下,对吲哚美辛治疗的大鼠结肠节段进行长时间孵育(4 - 24小时),导致[3H]dThd掺入DNA、iPGE和黏膜cAMP最终恢复到对照值。相反,在吲哚美辛治疗的大鼠结肠节段孵育(6小时)中加入吲哚美辛(0.25mM)导致iPGE和黏膜cAMP持续受到抑制,以及[3H]dThd掺入黏膜DNA持续增强。然而,体外将对照组大鼠(无体内药物暴露)的结肠节段与吲哚美辛或阿司匹林孵育长达24小时未能改变DNA合成,尽管培养液中iPGE显著降低且黏膜cAMP较低。后一观察结果表明,体内存在其他因素引发了吲哚美辛或阿司匹林治疗的大鼠中DNA合成的增强。外源性PGE2、D2、I2或F2α,每一种都增加了对照组、吲哚美辛或阿司匹林治疗的大鼠孵育结肠节段的内源性黏膜cAMP含量,但在体外均抑制了[3H]dThd掺入黏膜DNA。二丁酰cAMP而非二丁酰cGMP对体外[3H]dThd掺入DNA有类似的抑制作用。因此,目前的观察结果与内源性结肠PG合成对结肠上皮细胞增殖活性的抑制作用一致。这种作用可能通过cAMP介导。